Jean-Louis Paillasseur

Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

Pierre‐Régis Burgel, I. Durieu, R. Chiron et al. · American Journal of Respiratory and Critical Care Medicine · 2021 · 227 citations

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Pierre‐Régis Burgel, À. Munck, I. Durieu et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 127 citations

Impact of comorbidities on COPD-specific health-related quality of life

Pierre‐Régis Burgel, R. Escamilla, T. Pérez et al. · Respiratory Medicine · 2012 · 125 citations · Full text

Quality Of Life, Copd-specific Health-related Quality, Chronic Disease +5

Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality

Pierre‐Régis Burgel, Jean-Louis Paillasseur, Bernard Peene et al. · PLoS ONE · 2012 · 121 citations · Full text

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD

M. Zysman, Gaëtan Deslée, D. Caillaud et al. · International Journal of COPD · 2017 · 99 citations · Full text